(Reuters) -The U.S. Food and Drug Administration on Friday approved Pfizer Inc (NYSE:PFE)'s nasal spray for... By Maggie Fick PUURS, Belgium (Reuters) -U.S. drugmaker Pfizer (NYSE:PFE) is ready to ...

FILE PHOTO: Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. (Image Credits: Reuters) Pfizer CEO Albert Bourla on Monday said that the company might move ...

De Amerikaanse president Donald Trump raadt Amerikaanse farmaconcerns aan hun overzeese productie van geneesmiddelen te repatriëren naar de VS. Dat is geen goed vooruitzicht voor ons land.

Een van de toplui die bij het onderhoud met Trump aanwezig waren, was Albert Bourla, de ceo van Pfizer. Dat bedrijf is de voorbije jaren door zeer grote investeringen in zijn vestiging in Puurs ...

Pfizer has teamed up with Summit Therapeutics to assess whether one of the industry’s hottest cancer candidates works well with its antibody-drug conjugates (ADCs). Ivonescimab remains the ...

Shares of Pfizer (NYSE:PFE) have delivered negative returns since I started covering the stock and the last four months have not been great either as it is down another 12% since my previous ...

Pfizer's revenue has stabilized, and operational efficiency is improving, supporting a "Strong buy" rating with a 6.5% forward dividend yield. The market sentiment in the next few months is likely ...

After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., is returning to her previous employer: Big Pharma Pfizer. After ...

Feb 24 (Reuters) - Pfizer (PFE.N), opens new tab on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing ...

It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer. Pfizer’s decision to hire Patrizia Cavazzoni, a former top drug ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director ...

Pfizer's disclosure Friday that it is ending global development and commercialization efforts for its hemophilia B treatment Beqvez brings an inauspicious ending to a gene therapy that got its ...